0.00Open16.30Pre Close0 Volume0 Open Interest63.00Strike Price0.00Turnover4221.76%IV-0.33%PremiumDec 27, 2024Expiry Date16.57Intrinsic Value100Multiplier-5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9875Delta0.0036Gamma4.88Leverage Ratio-51.5781Theta0.0000Rho4.82Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet